Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenxian Shengmai Oral Liquid for Chronic Slow Arrhythmia (Yang Deficiency Syndrome)
ChiCTR-IPR-16007835Phase 4Not yet recruiting
- Sponsor
- Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in arrhythmia comparing Shenxian Shengmai oral liquid with Placebo (2 arms). Primary endpoint: Holter monitoring outcomes. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
Shenxianshengmai Oral Liquid
03
Conditions
arrhythmia
Beyond the preview
Go deeper on ChiCTR-IPR-16007835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007835.